天域生物科技股份有限公司关于控股股东所持公司部分股份质押的公告

Core Points - The announcement details the pledge of shares by the controlling shareholders of Tianyu Biotechnology Co., Ltd, specifically Mr. Luo Weiguo and Mr. Shi Dongwei [1][2] Group 1: Shareholding and Pledge Details - As of the announcement date, Mr. Luo Weiguo holds 37,251,829 shares, accounting for 12.84% of the total share capital, while Mr. Shi Dongwei holds 32,338,800 shares, accounting for 11.15% [1] - After the pledge, Mr. Luo has pledged a total of 22,000,000 shares, which is 59.06% of his holdings and 7.58% of the total share capital; Mr. Shi has pledged 29,000,000 shares, which is 89.68% of his holdings and 9.99% of the total share capital [1] - Together, Mr. Luo and Mr. Shi hold 69,590,629 shares, representing 23.98% of the total share capital, and after the pledge, they have pledged a total of 51,000,000 shares, which is 73.29% of their holdings and 17.58% of the total share capital [1] Group 2: Legal and Financial Status - Due to a legal dispute, 14,375,524 shares held by Mr. Luo are judicially frozen, and 3,181,856 shares held by Mr. Shi are also frozen due to a contractual dispute [2] - Both shareholders have good credit status and possess the financial capability to repay, with repayment funds sourced from their own funds; the risk associated with the pledged shares is controllable, and there is currently no risk of forced liquidation [2][3] Group 3: Impact on the Company - The pledged shares will not affect the company's main business, financing credit, financing costs, or ongoing operational capabilities [3] - The pledge will not influence the shareholders' ability to appoint directors to the company, nor will it affect the relationship between shareholders and the company regarding property, business, assets, or personnel [3]